We evaluated the optimal conditions for blood sampling for hematopoietic progenitor cells (HPCs) as estimated by the immature information program of the SE-9000 automated hematology analyzer. The HPC count was most stable when the blood samples were incubated at room temperature with ethylene-diaminetetraacetic acid dipotassium (EDTA-2K) as an anticoagulant. The HPC count should, however, be measured within 4 h after blood collection, even under optimal conditions. In contrast, the CD34+ cell count estimated by flow cytometric analysis was stable for at least 21 h after the blood samples were incubated with EDTA-2K at room temperature or 4°C. When appropriate blood samples were used, the HPC count in the peripheral blood significantly correlated with the CD34+ cell count in the peripheral blood and in the apheresis yields (r = 0.798 and 0.635, respectively); therefore, the HPC count is a reliable predictor for initiation of apheresis procedures to obtain sufficient HPCs for peripheral blood stem cell transplantation.

Bensinger W, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, Clarke E, Clift R, Hansen J, Shields T: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993;81:3158–3163.
Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995;86:3961–3969.
Passos-Coelho JL, Braine HG, Davis JM, Huelskamp AM, Schepers KG, Ohly K, Clarke B, Wright SK, Noga SJ, Davidson NE: Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 1995;13:705–714.
Elliott C, Samson DM, Armitage S, Lyttelton MP, McGuigan D, Hargreaves R, Giles C, Abrahamson G, Abboudi Z, Brennan M, Kanfer EJ: When to harvest peripheral-blood stem cells after mobilization therapy: Prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 1996;14:970–973.
Schots R, Van Riet I, Damiaens S, Flament J, Lacor P, Staelens Y, Steenssens L, van Camp B, De Waele M: The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996;17:509–515.
Armitage S, Hargreaves R, Samson D, Brennan M, Kanfer E, Navarrete C: CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 1997;20:587–591.
Yu J, Leisenring W, Bensinger WI, Holmberg LA, Rowley SD: The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield. Transfusion 1999;39:442–450.
Yamane T, Takekawa K, Tatsumi N: Possibility of identification of hematopoietic stem cells using a conventional blood cell counter. Eur J Haematol 1995;55:207–208.
Takekawa K, Yamane T, Suzuki K, Hino M, Tatsumi N: Identification of hematopoietic stem cells by the SE-9000 automated hematology analyzer in peripheral blood stem cell harvest samples. Acta Haematol 1997;98:54–55.
Pollard Y, Watts MJ, Grant D, Chavda N, Linch DC, Machin SJ: Use of the haemopoietic progenitor cell count of the Sysmex SE-9500 to refine apheresis timing of peripheral blood stem cells. Br J Haematol 1999;106:538–544.
Saigo K, Sugimoto T, Narita H, Nomura T, Kubota Y, Hara I, Takeuchi S, Kosaka Y, Matsumoto H, Ryo R, Kumagai S: Application of the stem cell monitor program for harvesting peripheral blood stem cells. Sysmex J Int 1999;9:151–159.
Akiyama H, Takasaki A, Katsuta I, Shiino Y, Ito Y, Kato N, Maruyama H, Ezaki H: Identification of the optimal time for peripheral blood stem cell harvest by automated hematology analyzer (in Japanese). Jpn J Med Technol 1999;48:1459–1463.
Yu J, Leisenring W, Fritschle W, Heimfeld S, Shulman H, Bensinger WI, Holmberg LA, Rowley SD: Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection. Bone Marrow Transplant 2000;25:1157–1164.
Nomura T, Kubota Y, Baba N, Saigo K, Taminato T: Evaluation of the optimal condition of blood sampling applied to the IMI (immature information) scattergram of the automated hematology analyzer SE-9000 (in Japanese). Jpn J Transfus Med 2001;47:639–645.
Park KU, Kim SH, Suh C, Kim S, Lee SJ, Park JS, Cho HJ, Kim KW, Lee K, Kim HJ, Park J, Joo Min Y, Kim JG, Kim T, Lee JH, Kim SB, Kim SW, Lee KH, Lee JS, Kim WK, Park CJ, Chi HS: Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34(+) cell count by flow cytometry in leukapheresis products. Am J Hematol 2001;67:42–47.
Wall DA, Oliver DA: Use of the hematopoietic progenitor cell parameter on the Sysmex SE-9500™ as a screening tool for circulating hematopoietic precursors in pediatrics. Infusion Ther Transfus Med 2001;28:267–270.
Saigo K, Kubota Y, Sugimoto T, Ryo R, Kumagai S: Estimation of hematopoietic stem cells by using automated hematology analyzers. Lab Medica Int 2002;19:14–16.
Vogel W, Kopp HG, Kanz L, Einsele H: Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens. J Cancer Res Clin Oncol 2002;128:380–384.
Ishii T, Kawasumi I, Matsumoto H: SE-9000 IMI channel: Focusing on the roles and functions of surfactant. Sysmex J Int 1997;7:123–128.
Saigo K, Sugimoto T, Takeuchi S, Kosaka Y, Ryo R, Kumagai S: Estimation of stem cell fractions in peripheral blood stem cell harvest by using an SE-9000 hematology analyzer. Acta Haematol 2000;103:157–161.
Gratama JW, Orfao A, Barnett D, Brando B, Huber A, Janossy G, Johnsen HE, Keeney M, Marti GE, Preijiers F, Rothe G, Serke S, Sutherland DR, Van der Schoot CE, Schmitz G, Papa S: Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry 1998;34:128–142.
Kubota Y, Tanaka T, Kitanaka A, Ohnishi Y, Waki M, Ishida T, Kamano H: Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase. EMBO J 2001;20:5666–5677.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.